BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1637833)

  • 1. Structural comparisons of meizothrombin and its precursor prothrombin in the presence or absence of procoagulant membranes.
    Pei G; Laue TM; Aulabaugh A; Fowlkes DM; Lentz BR
    Biochemistry; 1992 Aug; 31(30):6990-6. PubMed ID: 1637833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence resonance energy transfer study of shape changes in membrane-bound bovine prothrombin and meizothrombin.
    Chen Q; Lentz BR
    Biochemistry; 1997 Apr; 36(15):4701-11. PubMed ID: 9109682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma.
    Tans G; Janssen-Claessen T; Hemker HC; Zwaal RF; Rosing J
    J Biol Chem; 1991 Nov; 266(32):21864-73. PubMed ID: 1939210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The active site of membrane-bound meizothrombin. A fluorescence determination of its distance from the phospholipid surface and its conformational sensitivity to calcium and factor Va.
    Armstrong SA; Husten EJ; Esmon CT; Johnson AE
    J Biol Chem; 1990 Apr; 265(11):6210-8. PubMed ID: 2180944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes.
    Wu JR; Zhou C; Majumder R; Powers DD; Weinreb G; Lentz BR
    Biochemistry; 2002 Jan; 41(3):935-49. PubMed ID: 11790117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A).
    Côté HC; Stevens WK; Bajzar L; Banfield DK; Nesheim ME; MacGillivray RT
    J Biol Chem; 1994 Apr; 269(15):11374-80. PubMed ID: 8157669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylserine-containing membranes alter the thermal stability of prothrombin's catalytic domain: a differential scanning calorimetric study.
    Lentz BR; Zhou CM; Wu JR
    Biochemistry; 1994 May; 33(18):5460-8. PubMed ID: 8180168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane binding induces lipid-specific changes in the denaturation profile of bovine prothrombin. A scanning calorimetry study.
    Lentz BR; Wu JR; Sorrentino AM; Carleton JN
    Biophys J; 1991 Oct; 60(4):942-51. PubMed ID: 1742461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human factor V by meizothrombin.
    Tans G; Nicolaes GA; Thomassen MC; Hemker HC; van Zonneveld AJ; Pannekoek H; Rosing J
    J Biol Chem; 1994 Jun; 269(23):15969-72. PubMed ID: 8206891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin.
    Petrovan RJ; Govers-Riemslag JW; Nowak G; Hemker HC; Tans G; Rosing J
    Biochemistry; 1998 Feb; 37(5):1185-91. PubMed ID: 9477942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium ion modulation of meizothrombin autolysis at Arg55-Asp56 and catalytic activity.
    Stevens WK; Côté HF; MacGillivray RT; Nesheim ME
    J Biol Chem; 1996 Apr; 271(14):8062-7. PubMed ID: 8626490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the active-site conformations of bovine alpha-thrombin and meizothrombin(desF1) by electron spin resonance.
    Boxrud PD; Berliner LJ
    J Protein Chem; 1996 Feb; 15(2):231-42. PubMed ID: 8924207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
    Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
    Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple active forms of thrombin. IV. Relative activities of meizothrombins.
    Doyle MF; Mann KG
    J Biol Chem; 1990 Jun; 265(18):10693-701. PubMed ID: 2355015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the anticoagulant profile of meizothrombin.
    Stojanovski BM; Pelc LA; Zuo X; Pozzi N; Cera ED
    Biomol Concepts; 2018 Dec; 9(1):169-175. PubMed ID: 30864392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partially purified Echis carinatus venom cleaves active-site-mutated bovine prothrombin at two sites.
    Chen Q; Lord ST; Lentz BR
    Thromb Res; 1997 Mar; 85(5):369-75. PubMed ID: 9076894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
    Shim K; Zhu H; Westfield LA; Sadler JE
    Blood; 2004 Jul; 104(2):415-9. PubMed ID: 15039280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction, properties and specific fluorescent labeling of a bovine prothrombin mutant engineered with a free C-terminal cysteine.
    Chen Q; Lord ST; Lentz BR
    Protein Eng; 1996 Jun; 9(6):545-53. PubMed ID: 8862556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+ binding to meizothrombin desF1.
    Papaconstantinou ME; Gandhi PS; Chen Z; Bah A; Di Cera E
    Cell Mol Life Sci; 2008 Nov; 65(22):3688-97. PubMed ID: 18854941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative roles of factor V(a) and phosphatidylserine-containing membranes as cofactors in prothrombin activation.
    Weinreb GE; Mukhopadhyay K; Majumder R; Lentz BR
    J Biol Chem; 2003 Feb; 278(8):5679-84. PubMed ID: 12438309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.